Andrea Brugnolo

Genoa, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease.

Exploring the spatial covariance of cerebral vascular density and amyloid burden in Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 15, 2026

[18F]Fluorodeoxyglucose positron emission tomography ([18F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy Continuum.

[18F]Fluorodeoxyglucose positron emission tomography ([18F]FDG PET) Characterizes Neurodegeneration Levels Across the α-Synucleinopathy Continuum.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 13, 2025

Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum.

Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the α-Synucleinopathy Spectrum.

Journal: Neurology
Published: October 10, 2025

Care partners of people with dementia: the role of the "waiting room".

Care partners of people with dementia: the role of the "waiting room".

Journal: Neurodegenerative disease management
Published: August 04, 2025

Neurotransmitter landscape and neurodegeneration patterns in Alzheimer's Disease.

Neurotransmitter landscape and neurodegeneration patterns in Alzheimer's Disease.

Journal: Neurobiology of aging
Published: August 04, 2025

How can we define a brain health chart? A narrative review and a proposal.

How can we define a brain health chart? A narrative review and a proposal.

Journal: Journal of Alzheimer's disease : JAD
Published: May 26, 2025

Cerebrospinal fluid NPTX2 and [18F]FDG PET track serotonergic vulnerability to neurodegeneration in prodromal Alzheimer's disease.

Cerebrospinal fluid NPTX2 and [18F]FDG PET track serotonergic vulnerability to neurodegeneration in prodromal Alzheimer's disease.

Journal: Alzheimer's research & therapy
Published: March 31, 2025

Enriched resting-state EEG prediction of cognitive decline in prodromal Alzheimer's disease: a machine-learning approach.

Enriched resting-state EEG prediction of cognitive decline in prodromal Alzheimer's disease: a machine-learning approach.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
Published: February 13, 2025

Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.

Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD
Published: November 26, 2024

Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis.

Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer's Disease: Clues from [18F]FDG PET Voxel-Wise Analysis.

Journal: Journal of Alzheimer's disease : JAD
Published: September 06, 2024

Personality traits and levels of anxiety and depression among martial artists: a cross-sectional study.

Personality traits and levels of anxiety and depression among martial artists: a cross-sectional study.

Journal: BMC psychology
Published: August 12, 2024

Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study.

Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study.

Journal: NPJ Parkinson's disease
Published: July 01, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026